Study suggests COVID-19 could be a potential trigger for ME/CFS.
In a world first, Gold Coast researchers have made an important breakthrough in understanding the cause of Chronic Fatigue Syndrome.
A diagnostic test for Chronic Fatigue Syndrome could be available within five years following the awarding of $4 million in funding to one of Australia’s foremost authorities on the condition.
Chronic Fatigue Syndrome researchers have discovered a cell receptor which could be a key contributing factor to CFS, providing a much clearer picture of how to tackle the debilitating illness.
New findings regarding the pathology of Chronic Fatigue Syndrome (CFS) are bringing Griffith University researchers closer to identifying the cause of this disabling illness.
Ground-breaking research at Griffith University into Chronic Fatigue Syndrome (CFS) is leading the way for the development of a new screening tool for the condition.
Sufferers of Chronic Fatigue Syndrome are set to benefit with the dual launch of a specialist Griffith University clinic and smartphone app, both aimed to manage their illness and improve health outcomes.
Chronic fatigue syndrome, or myalgic encephalomyelitis, is a highly debilitating, but often misunderstood, disorder, writes Professor Sonya Marshall-Gradisnik from the Griffith Health Institute.
People living with chronic fatigue are set to benefit with the opening today (Dec 2), of the National Centre for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University.
Researchers find overlap in long COVID and ME/CFS patients using MRI.
